The Chancellor, Philip Hammond, recently announced his formal backing of the National Infrastructure Commission’s recommendation to deliver a railway station on the Cambridge Biomedical Campus by 2022. Central Government will invest £5 million of matched funding to make a new railway station at Addenbrooke’s a reality to help with planned growth in the region and provide significantly improved transport links.
Heidi, who worked with Transport Minister, Chris Grayling to promote plans for the station in the early stages, said: “I have been working closely with Government and key local stakeholders to advance plans to deliver this railway station. The Chancellors announcement in the Autumn Statement demonstrates Government’s commitment to supporting the Cambridge Biomedical Campus to reach its full potential as a world renowned center of excellence, thereby securing continued economic growth for the region and beyond.”
“This announcement takes us closer to delivering a much needed railway station in the south of the city. But make no mistake, there is still much work to do in developing other important infrastructure projects, such as an all-ways interchange at Girton, improvements to the A505 and a railway crossing at Foxton. We need all of these projects to reduce congestion and increase the area’s productivity through improved connectivity.”
Cambridge is a key City in the Cambridge-Milton Keynes-Oxford arc, recognised by the National Infrastructure Commission as containing some of the country’s most productive and innovative towns and cities. These places deliver growth and prosperity that benefits the whole country. Recent reports published by the National Infrastructure Commission and the West Anglia Taskforce identify the area’s transport links as the greatest potential obstacle to future growth.
In a visit to the Cambridge Biomedical Campus in August this year, Transport Secretary Chris Grayling discussed plans for a train station at the site, lending his support to the scheme, saying that he was “convinced” of the need for a new station in the south of the city.
Dr Andy Williams, VP for Cambridge Strategy and Operations at AstraZeneca, said: “We are delighted at this news, which will bring significant and sustainable benefits to the Cambridge region and the UK life sciences sector. It has been a real team effort by local MPs, the Combined Authority, Greater Cambridge Partnership, businesses and organisations.
“We thank Heidi Allen MP for her personal contribution to and leadership of this cause over the past couple of years.
“This station will enhance connectivity within the ‘Golden Triangle’ of Cambridge, Oxford and London and internationally, which in turn will help drive growth and investment in UK science and innovation.”